Page 5 - 《中国药房》2022年13期

CHINA PHARMACY

Volume 33，Number 13，July 15，2022

Semimonthly
Table of Contents

Discussion on development difficulties and countermeasures of complex preparations in China …………………
………………………………………………………………… SONG Bo，ZHENG Xiao，SHI Juan，CAO Feng（1537）
Interpretation and thinking of indicators of pharmaceutical administration in National Tertiary Public Hospitals

Performance Evaluation Operational Manual（2022 edition）……………………………………………………
………………………………………………… XU Silu，WU Nan，CAI Ning，ZHAO Min，PAN Jie，WEI Jifu（1541）
Process risk assessment of vaccine supply chain based on combination weighting method ………………………
………………………………………………………………………………………… YANG Manyi，NIU Lixia（1548）
Common protocol deviations and improvement methods and precautions in drug clinical trials …………………
…………………………… XIE Jiangchuan，XIE Linli，CAO Liya，PAN Xinmei，MA Pan，CHEN Yongchuan（1554）
Quantitative evaluation for payment policy of diagnosis-related groups in China based on PMC index model …
…………………………………………… CHEN Jiaxin，WU Tingting，FU Manxia，HOU Yanhong，WU Fang（1559）
Preparation of Legumain enzyme and mitochondrial double-stage targeted harmine liposome and evaluation of
its in vitro characterization …………………………………………………………………………………………
………… Ipargul·Hafiz，HE Hongji，WANG Zhaozhi，LI Zhezhe，Kadirya·Akram，BAI Jingya，WANG Mei（1565）
Myocardial protective effect of Yangxin dingji capsule on diabetic cardiomyopathy model golden hamsters
…………… ZHONG Yi，LIU Gang，MA Guoping，DING Baozhu，LI Xiaoxia，LIU Haoying，LIANG Wenjie（1573）

Study on the mechanism of Poria cocos polysaccharides on the regulation of gluconeogenesis in liver of type 2
diabetic mellitus model rats …………………………………………………………… HAN Sijie，PAN Xiang，
ZHU Qianqian，ZHANG Dandan，ZHANG Hanrui，FANG Jingxian，WEI Qiong，LIU Dan，YE Xiaochuan（1581）
Vasorelaxant effects and mechanism of polyphenol compound LM49 on isolated thoracic aorta of rats …………
……………… ZHANG Mengru，GAO Yan，YANG Caihong，ZHAO Chengxiao，FENG Xiu’e，LI Qingshan（1588）
Preparation and evaluation of doxorubicin-loaded red blood cell membrane chitosan-targeted nanoparticles ……
………… HONG Weiyong，ZHOU Xuhui，JIN Chenhao，WANG Jinming，GUO Fangyuan，YANG Gensheng（1594）
Content determination of ephedrine hydrochloride and pseudoephedrine hydrochloride in Shexiang zhuanggu
plaster and its quality evaluation ……………………………………………………………………………………
………… YANG Yuanyuan，ZHANG Nan，XIE Zhimin，HU Jing，QU Tong，TAO Hongxun，CHEN Zhiyong（1600）
Optimization of natural deep eutectic solvent extraction of phenylethanoid glycosides from Cistanche deserticola
by response surface methodology coupled with genetic algorithm ………………………………………………
DONG Jiani，ZHAO Longshan，BO Yukun，YANG Dan，YANG Xuemiao，TAN Yimeng，AN Ming，WU Guodong（1605）
Effects of intrathecal injection of resveratrol on sense of pain and OPG/RANK/RANK-L signal pathway in rats
with bone cancer pain ………………………… ZHOU Fang，LIN Tao，DAI Yue’e，ZHOU Qin，JIANG Rong（1612）
Mechanism of Mayuan tongbian zhitong decoction on improving slow-transmission constipation in rats by

regulating AMPK/eNOS signaling pathway ………………………………………………………………………
………… XIE Changying，YU Xuchao，GE Wei，WU Chengcheng，XIAO Huirong，LIN Shenqi，LIU Jinlian（1617）
Pharmacoeconomic evaluation of pyrotinib combined with capecitabine in the second-line treatment of HER-2
positive patients with advanced breast cancer ……………………………………… WANG Lin，CHEN Zaiyu（1624）
Clinical observation of albumin-bound paclitaxel combined with oxaliplatin in the first-line treatment of advanced
gastric cancer …………… ZHU Wanli，WANG Peng，WANG Hui，WANG Hongli，CHENG Peng，GOU Fei（1630）